🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Neo-adjuvant treatment (so drug before surgery) is a complete game changer … for the patients and for drug development… just amazing. Professor Georgina Long AO (Bluesky @gvlongphdmd) gave an incredibly captivating talk at #SMR2022

Nivolumab reduced the risk of recurrence by 58% (HR 0.42) and showed meaningful reduction in DMFS (HR 0.47) compared to placebo in pts with resected Stage IIB/C melanoma - first results of the Checkmate 76K study presented by Professor Georgina Long AO (Bluesky @gvlongphdmd) great job!

"We welcome #Budget2023 anncmt of $14.8m over 4 yrs for MIA to develop National Melanoma Nurse Network. 1 of 25 recs in #StateOfTheNation report, 1st to have gov funding. Look forward to working with Fed Gov & other orgs to benefit #melanoma patients/families.” Matthew Browne CEO

Proud that Clarivate has recognised MIA's @ProfRScolyerMIA, Professor Georgina Long AO (Bluesky @gvlongphdmd), A/Prof @amenzies9, A/Prof Matteo Carlino & former faculty Prof #RickKefford as Highly Cited Researchers 2022, based on exceptional citation #impact. clarivate.com/highly-cited-r… #HighlyCited2022 Clarivate for Academia & Government

Join us for MPA-MIA Melanoma Community Webinar Two for updates on #Immunotherapy & targeted therapies. Presenters: Med Oncology Fellow Dr Piyush Grover, patient Karen van Gorp. Professor Georgina Long AO (Bluesky @gvlongphdmd) will join Q&A. Free via zoom. Thurs 24 Nov 7-8pm AEDT. Register> bit.ly/3Vmd7fb

A must-watch video for pathologists on pathological assessment in #melanoma #neoadjuvant therapy. Great work @ProfRScolyerMIA and #DrRobRawson. #pathology

Our chair @nicolafoneil comments on the recent ESMO - Eur. Oncology study showing that 52% of female oncologists under 40 felt that gender impacted on their professional career with 49% believing that little/no progress had been made in closing the gender gap thelimbic.com/oncology/long-… #IWD2023

#ASCO23, Piyush Grover recipient of the MRF-ASCO merit award - collected retrospective data on 613 patients with stage IIIA melanoma from Australia, Europe & US. He concludes that a prospective randomized trial is now needed to determine which patients benefit from adjuvant therapy!

1) Professor Georgina Long AO (Bluesky @gvlongphdmd) #melanoma #immunotherapy ROCKSTAR Melanoma Institute Australia talks eval of predictive biomarkers 4 resp 2 #PD1 / CD8 TMB & IFNg signatures/lots of data #ASCO2023 Melanoma Support Ireland 🖤 Melanoma Canada Deborah Thomassen Melanoma Research Foundation

MOGA congratulates Professor Georgina Long AO for being awarded the Medical Oncology Group of Australia - Novartis Oncology Cancer Achievement Award 2023, in recognition of her outstanding contribution to medical oncology in Australia. moga.org.au/2023-asm

Our inaugural paper, our manifesto is now out in The Lancet Oncology . This paper describes our mission, vision, and guiding principles. We also now invite you all to join our movement- our website is now live. thelancet.com/journals/lanon…

Massive congratulations Professor Georgina Long AO (Bluesky @gvlongphdmd) on this richly deserved honour recognising your incredible contributions in #melanoma ! Your work has not only transformed this disease & saved thousands of lives but has also impacted many other cancers! Melanoma Institute Australia University of Sydney Sydney Health

Great talk from Piyush Grover discussing some promising options for Tx of immunotoxicity at #MOGA23 (with a few shout-outs to #perthisok 👏🏻)

Fantastic insights on steroid sparing therapies for iRAEs and the challenges managing patients in this area. #MOGA23 So clearly presented and loved ths puns! Medical Oncology Group of Australia (MOGA)

Kudos to Professor Georgina Long AO (Bluesky @gvlongphdmd) for receiving the #ESMO23 Women for Oncology Award! So well deserved! An inspiring leader, with exceptional work that extends beyond the melanoma field. I have no words to thank her for the impact she had on my career after working with her at Melanoma Institute Australia

Congratulations Professor Georgina Long AO (Bluesky @gvlongphdmd) and @ProfRScolyerMIA. Richly deserved.

Lovely to be invited to write an opinion piece for ASCO Daily News! #lcsm #pneumonitis Radiation Pneumonitis vs CPI Pneumonitis: Understanding the Differences, Similarities of Each and Impact on Patient Care dailynews.ascopubs.org/do/radiation-p…

Under-studied - management of reactions means patients continue therapy. Omalizumab for management of #hypersensitivity reactions to #anticancer drugs - Grover - 2024 - Internal Medicine Journal - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/im… Piyush Grover UWA Research

🆕article in press: Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma Professor Georgina Long AO (Bluesky @gvlongphdmd) doi.org/10.1016/j.anno…

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma. - Annals of Oncology annalsofoncology.org/article/S0923-… Thanks to our 34 collaborators across Australia, USA, and Europe. Largest analysis in pts with IIIA melanoma. Need for a RCT. Professor Georgina Long AO (Bluesky @gvlongphdmd) Melanoma Institute Australia